Cell Therapy in the Treatment of Coronary Heart Disease

Elena V Chepeleva1,2

  • 1Federal State Budgetary Institution National Medical Research Center Named after Academician E.N. Meshalkin of the Ministry of Health of the Russian Federation, 15, Rechkunovskaya Str., 630055 Novosibirsk, Russia.

Insights

Cell therapy offers a promising approach to restore heart function after myocardial infarction, even with reperfusion treatments. This review explores cell types, delivery, and mechanisms for cellular cardiomyoplasty in heart disease.

Area of Science:

  • Regenerative Medicine
  • Cardiology
  • Biotechnology

Background:

  • Heart failure is a major cause of death post-myocardial infarction.
  • Reperfusion therapies do not always prevent myocardial damage and heart failure.
  • Improving function in damaged heart areas is a key research focus.

Purpose of the Study:

  • To review cell types for cellular cardiomyoplasty.
  • To present findings on cell therapy for coronary heart disease.
  • To discuss cell delivery, dosage, and treatment mechanisms.

Main Methods:

  • Literature review of experimental and clinical studies.
  • Analysis of cell characteristics for cardiac repair.
  • Discussion of cell delivery strategies and dosage optimization.

Main Results:

  • Various cell types show potential for cardiac regeneration.
  • Experimental and clinical studies indicate efficacy of cell therapy.
  • Delivery methods, dosage, and mechanisms are crucial for treatment success.

Conclusions:

  • Cell therapy is a promising strategy for restoring cardiac function post-myocardial infarction.
  • Further research into optimal cell types, delivery, and mechanisms is warranted.
  • Cellular cardiomyoplasty holds potential for treating heart failure in coronary heart disease.